Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Stati Uniti
  4. Nasdaq
  5. Viatris Inc.
  6. Notizie
  7. Altre lingue
    VTRS   US92556V1061

VIATRIS INC.

(VTRS)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietàFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su VIATRIS INC.
13:17BIOCON: Biologics First-Ever Interchangeable Biosimilar Insulin Glargine, Co-Developed wi..
20/10VIATRIS': Semglee Insulin Injection to be Listed on Express Scripts' National Preferred F..
20/10Cigna's pharmacy benefit unit to prefer cheaper insulin drug from Viatris
13/10VIATRIS INC.: to Release Third Quarter 2021 Financial Results on Nov. 8, 2021
12/10VIATRIS: Mapi Pharma to Present Series of Recent Advancements for Treating Multiple Scler..
11/10VIATRIS: Named Fifth on Fortune's Change the World List
04/10PFIZER: to Transfer Upjohn Business to India's Mylan for $24 Million
29/09INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Via..
17/09VIATRIS: Former Mylan executive pleads guilty to insider trading
03/09JOHNSON & JOHNSON: Lifesaving TB Medicines Still Out of Reach for Children in High-Burden..
30/08VIATRIS INC.: to Participate in Citi's 16th Annual BioPharma Conference
30/08VIATRIS INC.: to Participate in BofA Global Healthcare Conference
12/08VIATRIS: Plant owner in talks with WVU to transfer shuttered facility
09/08VIATRIS: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA..
09/08Viatris Inc. Provides Revenue Guidance for the Second Half 2021
09/08VIATRIS INC: Results of Operations and Financial Condition (form 8-K)
09/08Viatris Inc. Raises Earnings Guidance for 2021
09/08VIATRIS: Q2 Adjusted Earnings Turn Negative, Revenue Rises; Raises Full-Year 2021 Outlook
09/08VIATRIS: Q2 Earnings Snapshot
09/08VIATRIS: Reports Strong Second Quarter Results
09/08VIATRIS: Earnings Flash (VTRS) VIATRIS Posts Q2 Revenue $4.58B, vs. Street Est of $4.401B
09/08Viatris Inc. Declares Quarterly Dividend, Payable on September 16, 2021
09/08Viatris Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
29/07VIATRIS: FDA allows automatic 'generic' swap for brand-name insulin
29/07VIATRIS INC.: and Biocon Biologics Receive Historic Approval for First Interchangeable Bi..
29/07Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable B..
27/07VIATRIS: US District Court Dismisses Class Action Suit Against Viatris, Pfizer Over EpiPe..
27/07VIATRIS: Mylan Wins Dismissal of Kansas EpiPen® Direct Purchaser Case
21/07VIATRIS: Biden urged to act on outsourcing of West Virginia jobs
16/07VIATRIS: Pfizer agrees to pay $345 mln to resolve EpiPen pricing lawsuit
08/07VIATRIS INC.: to Release Second Quarter 2021 Financial Results on Aug. 9, 2021
06/07The highest-grossing companies in the US
06/07Les entreprises américaines générant le plus de chiffre d’affaires
02/07The United Steelworkers Union Reaches Effects Bargaining Agreement with Viatris over Mo..
01/07VIATRIS INC: Entry into a Material Definitive Agreement, Creation of a Direct Financial O..
01/07Viatris Inc. Announces Amended and Restated Revolving Credit Agreement
25/06VIATRIS INC.(NASDAQGS: VTRS) dropped from Russell 1000 Value-Defensive Index
25/06VIATRIS INC.(NASDAQGS: VTRS) dropped from Russell 1000 Defensive Index
24/06VIATRIS: Mylan Wins Significant Summary Judgment Rulings in Kansas EpiPen® Class Action
17/06VIATRIS INC: Other Events (form 8-K)
11/06IRS Embraces Role as 'Stimmies' Provider
25/05VIATRIS INC.: to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
12/05VIATRIS: Reports Strong First Quarter 2021 Financial Results, Reaffirms 2021 Guidance and..
10/05Coty, Marriott fall; Party City, Viatris rise
10/05VIATRIS: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA..
10/05SECTOR UPDATE: Health Care Stocks Hanging On For Modest Rise
10/05MIDDAY REPORT: US Stocks Mixed in Midday Trading as High Base Metal Prices Abet Inflation..
10/05SECTOR UPDATE: Health Care Stocks Trade Higher Premarket Monday
10/05VIATRIS INC: Results of Operations and Financial Condition, Financial Statements and Exhi..
10/05Viatris Inc. Announces Inaugural Quarterly Dividend, Payable on June 26, 2021
10/05VIATRIS: Swings to Q1 Loss, Revenue Increases; Reaffirms 2021 Revenue Outlook
10/05VIATRIS: Earnings Presentation
10/05VIATRIS: Q1 2021 Non-GAAP Reconciliations
10/05VIATRIS: Q1 Earnings Snapshot
10/05VIATRIS INC.: Reports Strong First Quarter 2021 Financial Results, Reaffirms 2021 Guidanc..
10/05VIATRIS: Earnings Flash (VTRS) VIATRIS Posts Q1 Revenue $4.4B, vs. Street Est of $4.197B
10/05GUIDANCE: (VTRS) VIATRIS Forecasts Fiscal Year 2021 Revenue Range $17.2B - $17.8B
10/05Viatris Inc. Reaffirms Earnings Guidance for the Year 2021
10/05Viatris Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
06/05VIATRIS INC.: Releases Inaugural Sustainability Report, Reinforcing its Commitment to Bet..
04/05PFIZER: First-Quarter Earnings Beat Street; Raises 2021 Outlook to Reflect Increased Vacc..
30/04VIATRIS INC.: to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
29/04VIATRIS INC.: to Participate in BofA Securities 2021 Health Care Conference
27/04ITALY JUDGE SENDS BAYER, NOVARTIS TO: sources
26/04BIOCON: Unit Gets European Commission's Approval for Biosimilar of Cancer Drug
26/04Biocon Biologics and Viatris Receive European Commission Approval for Biosimilar Bevaci..
12/04VIATRIS INC.: to Release First Quarter 2021 Financial Results on May 10, 2021
15/03EXCLUSIVE: U.S. Congress launches probe into multibillion-dollar 'clean coal' tax credit
08/03VIATRIS: Gets Tentative FDA Approval For Generic Asthma Drug Due to Pending Patent Litiga..
08/03VIATRIS INC.: and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbr..
08/03Viatris Inc. and Kindeva Drug Delivery L.P. Announce FDA Tentative Approval of the Firs..
05/03VIATRIS: Initial Insider Trading Report (SEC Filing - 3)
04/03VIATRIS INC.: to Participate in Barclays Global Healthcare Conference
03/03ASTRAZENECA: Wins Patent Claim Lawsuit Against Mylan Pharmaceuticals, Kindeva Drug Delive..
03/03ASTRAZENECA: victoire judiciaire face à Mylan et Kindeva
1  2  3  4Pross.
Prossimo evento su VIATRIS INC.